MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia - PubMed
- ️Thu Jan 01 1998
. 1998 Nov 26;17(21):2711-7.
doi: 10.1038/sj.onc.1202212.
Affiliations
- PMID: 9840935
- DOI: 10.1038/sj.onc.1202212
MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia
D Daphna-Iken et al. Oncogene. 1998.
Abstract
Prior studies have identified Fibroblast Growth Factor-8 (Fgf8) as a possible proto-oncogene in mouse mammary tumorigenesis. We now report on the generation of two types of Fgf8 transgenic mice that each utilize the mouse mammary tumor virus (MMTV) promoter. The first transgene (MMTV-Fgf8b) results in the overexpression of the FGF8b isoform exclusively. Male and female MMTV-Fgf8b transgenic mice are viable and fertile. RNA for FGF8b is detected in mammary gland and salivary gland tissues of transgenic mice by Northern blot analysis. Nearly 85% of breeding transgenic female mice developed mammary lobular adenocarcinomas by 12 months of age, while no tumors developed in non-transgenic littermates. Salivary gland tumors occurred in some animals, always in association with mammary tumors. Several MMTV-Fgf8b transgenic mice had lung metastases at necropsy. The second transgene (MMTV-Fgf8) uses the entire Fgf8 gene and potentially encodes all FGF8 isoforms. Fgf8 is expressed by this transgene in several tissues in addition to those described above, notably the ovaries. The two MMTV-Fgf8 founders developed mammary ductal adenocarcinomas at five and eight months of age, and both displayed ovarian stromal hyperplasia. The founders expressing either transgene did not successfully nurse their pups. These results demonstrate that production of FGF8b, and possibly other FGF8 isoforms, in the mammary and salivary glands contributes to oncogenesis, and that ovarian expression results in stromal hyperplasia.
Similar articles
-
Amundadottir LT, Johnson MD, Merlino G, Smith GH, Dickson RB. Amundadottir LT, et al. Cell Growth Differ. 1995 Jun;6(6):737-48. Cell Growth Differ. 1995. PMID: 7669729
-
Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.
Kapoun AM, Shackleford GM. Kapoun AM, et al. Oncogene. 1997 Jun 19;14(24):2985-9. doi: 10.1038/sj.onc.1201146. Oncogene. 1997. PMID: 9205106
-
TGF beta regulation of cell proliferation.
Moses HL, Arteaga CL, Alexandrow MG, Dagnino L, Kawabata M, Pierce DF Jr, Serra R. Moses HL, et al. Princess Takamatsu Symp. 1994;24:250-63. Princess Takamatsu Symp. 1994. PMID: 8983080 Review.
-
MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways.
Callahan R, Smith GH. Callahan R, et al. Oncogene. 2000 Feb 21;19(8):992-1001. doi: 10.1038/sj.onc.1203276. Oncogene. 2000. PMID: 10713682 Review.
Cited by
-
Nicholes K, Guillet S, Tomlinson E, Hillan K, Wright B, Frantz GD, Pham TA, Dillard-Telm L, Tsai SP, Stephan JP, Stinson J, Stewart T, French DM. Nicholes K, et al. Am J Pathol. 2002 Jun;160(6):2295-307. doi: 10.1016/S0002-9440(10)61177-7. Am J Pathol. 2002. PMID: 12057932 Free PMC article.
-
FGF8 isoform b expression in human prostate cancer.
Gnanapragasam VJ, Robinson MC, Marsh C, Robson CN, Hamdy FC, Leung HY. Gnanapragasam VJ, et al. Br J Cancer. 2003 May 6;88(9):1432-8. doi: 10.1038/sj.bjc.6600875. Br J Cancer. 2003. PMID: 12778074 Free PMC article.
-
Cell signaling regulation in salivary gland development.
Suzuki A, Ogata K, Iwata J. Suzuki A, et al. Cell Mol Life Sci. 2021 Apr;78(7):3299-3315. doi: 10.1007/s00018-020-03741-2. Epub 2021 Jan 15. Cell Mol Life Sci. 2021. PMID: 33449148 Free PMC article. Review.
-
Raimondi AR, Vitale-Cross L, Amornphimoltham P, Gutkind JS, Molinolo A. Raimondi AR, et al. Am J Pathol. 2006 May;168(5):1654-65. doi: 10.2353/ajpath.2006.050847. Am J Pathol. 2006. PMID: 16651631 Free PMC article.
-
FGF8 promotes colorectal cancer growth and metastasis by activating YAP1.
Liu R, Huang S, Lei Y, Zhang T, Wang K, Liu B, Nice EC, Xiang R, Xie K, Li J, Huang C. Liu R, et al. Oncotarget. 2015 Jan 20;6(2):935-52. doi: 10.18632/oncotarget.2822. Oncotarget. 2015. PMID: 25473897 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical